Crossmark

Treatment fidelity monitoring, reporting and findings in a complex aphasia intervention trial: a substudy of the Very Early Rehabilitation in SpEech (VERSE) trial

Crossref DOI link: https://doi.org/10.1186/s13063-022-06433-3

Published Online: 2022-06-16

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Godecke, Erin http://orcid.org/0000-0002-7210-1295
Brogan, Emily

Ciccone, Natalie

Rose, Miranda L.

Armstrong, Elizabeth

Whitworth, Anne

Ellery, Fiona

Holland, Audrey

Middleton, Sandy

Rai, Tapan

Hankey, Graeme J.

Cadilhac, Dominique

Bernhardt, Julie
Funding

Funding for this research was provided by:

National Health and Medical Research Council (1044973)

Tavistock Trust for Aphasia

Edith Cowan University
License Information

Text and Data Mining valid from 2022-06-16

Version of Record valid from 2022-06-16
More Information

Article History

Received: 25 May 2021

Accepted: 27 May 2022

First Online: 16 June 2022

Declarations

:

: The trial was approved by hospital ethics committees and all participants gave written informed consent using aphasia friendly consent processes.This study had Nationals Ethics approval via National Mutual Acceptance through The Austin Hospital (HREC13/Austin/101). All sites had site-specific agreements ethics approval based on the National Mutual Acceptance.

: Not applicable as individual data not used.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below